Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sleep Coverage Policy Comments Expose Dissent Over Merits Of Home Testing

This article was originally published in The Gray Sheet

Executive Summary

CMS is seeking additional input on how the diagnostic test performance of unattended, portable, multi-channel home sleep testing compares to facility-based testing in diagnosing obstructive sleep apnea (OSA)

You may also be interested in...



MCAC To Scrutinize Home Sleep Tests; Negative Tech Assessment Released

The effectiveness of unattended portable multi-channel home sleep test devices as an alternative to facility-based obstructive sleep apnea diagnosis (OSA) will be evaluated at an upcoming Medicare Coverage Advisory Committee meeting

MCAC To Scrutinize Home Sleep Tests; Negative Tech Assessment Released

The effectiveness of unattended portable multi-channel home sleep test devices as an alternative to facility-based obstructive sleep apnea diagnosis (OSA) will be evaluated at an upcoming Medicare Coverage Advisory Committee meeting

Sleep Test Coverage Policy, ResMed/Respironics Talks Could Awaken Market

ResMed plans to work with Respironics to generate data that will raise the public and professional profile of sleep-disordered breathing (SDB) devices, which have an estimated $600 mil. U.S. market potential

Latest Headlines
See All
UsernamePublicRestriction

Register

MT020517

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel